All News

Analysis shows that providers aren't including information about all available options when counseling their patients on CHCs.

Unprotected sex without immediate adverse events may empower women to believe they are not at high risk.

Three tests are now FDA-approved for triaging pelvic masses in asymptomatic women. 

Dishonesty from patients can not only undermine care, it can cause unexpected harm.

Failure to recognize the warning signs led to poor outcomes for mother and child.

Plan your ACOG 2019 trip with this rundown on board members - both past and current - authors and collaborators who will be presenting in Nashville.

Knowledge of a woman's reproductive span can help ob/gyns identify patients who may be at risk.

Testing circulating concentrations of placental growth factor could improve diagnostic time in suspected preeclampsia cases.

Talking with patients about their daughters is one way to build a practice focused on caring for girls, adolescents, and young adults.

Earlier trials are contradicted by the results of a new study, and ob/gyns may want to rethink their prescribing habits.

The proposed changes address mammographic technology, enhancing quality standards, and improving the way results of screening are handled throughout the healthcare system.

A new committee opinion updates ob/gyns about properly identifying and treating survivors in compliance with the necessary medical and legal requirements.

In this Medical News Minute, Dr. Bobby Lazzara discusses the findings of a recent study that examined rates and trends of severe maternal morbidity in terms of race.

Rising incidence rates of hepatitis C virus among pregnant women could indicate the need for universal screening, but as always, everything comes down to cost.

An analog of an endogenous human hormone has been approved as treatment, but it comes with a steep price tag.

A new study suggests that previous research has underestimated the impact of low-intensity movement in reducing CVD risk for women over 63.

Editorial Board member Christian Pettker, MD, wants to know whether Contemporary OB/GYN's readers are persuaded by the existing data about gum-chewing and prevention of ileus.

Maternal and fetal outcomes complicated by SLE require that patient, rheumatologist, and ob/gyn work as a team.  

Responsibility, anxiety, and expectations converge for an on-duty resident.

Patient communication and preoperative consent are the main issues in this case.

Physicians and pregnant patients with OUD may have a communication disconnect when it comes to postpartum contraception counseling.

Most physicians consider the practice safe for adolescents, but a recent survey indicates there is still a training and education gap that must be filled. 

As more states turn to punitive policies to discourage OUD among pregnant women, Dr. Lockwood and Dr. Wolfson examine what the ob/gyn's role in the debate should be. 

Do you know how to differentiate precancerous from cancerous vulvar lesions?

New research disagrees with current beliefs on how endometriosis impacts ART and miscarriage risk.

A new study helps to characterize the relation between ovarian fixation and SST on TVS and specific endometriosis types and locations.

Findings suggest 3D mammography may have advantages over 2D mammography in several areas when it comes to cancer diagnosis in younger women.